Ajinomoto Bio-Pharma Services
Satoshi Katayama has over 20 years of R&D and strategy development experience in the pharmaceutical contract development and manufacturing industry. At Ajinomoto Bio-Pharma Services, he is responsible for corporate governance of the global Aji Bio-Pharma sites (United States, Belgium and Japan).
Mr. Katayama began his career with Ajinomoto as a process chemist for the CDMO business in 1994. In 2000, he worked as a process chemist at Ajinomoto OmniChem in Belgium. In 2002, he returned to Japan to lead the Bio-Fine Laboratories as a senior researcher. In 2015, he became General Manager of the Bio-Fine Laboratories Process Chemistry group. In 2017, Mr. Katayama moved to Ajinomoto Group headquarters in Tokyo and started working in the Bio-Pharma Services Department as the Senior Manager of the Planning (Strategy) Group. In 2020, he was promoted to his current position.
Mr. Katayama holds a B.S. and a master’s degree in Engineering from Tokyo Institute of Technology.
This person is not in any offices
Ajinomoto Bio-Pharma Services
Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates.